CD8A and neoplasm: Bintrafusp alfa (BA) is a cutting-edge dual blockade of TGF-β and PD-L1, demonstrating the anti-tumor efficacy on metastatic OC by promoting tumor-infiltrating CD8+ T cells and provoking the immune response within the TME [87].